Home > Financial Ratios > AKUMS DRUGS & PHARMACEUTICALS

AKUMS DRUGS & PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for AKUMS DRUGS & PHARMACEUTICALS
Please provide your vote to see the results

AKUMS DRUGS & PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) -59.12655.88-122.1254.92-1.40

What is the latest Core EBITDA Growth ratio of AKUMS DRUGS & PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of AKUMS DRUGS & PHARMACEUTICALS is -59.12 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar2024-59.12
Mar2023655.88
Mar2022-122.12
Mar202154.92
Mar2020-1.40

How is Core EBITDA Growth of AKUMS DRUGS & PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2024 -59.12
Negative
Mar2023 655.88
Positive
Mar2022 -122.12
Negative
Mar2021 54.92
Positive
Mar2020 -1.4 -

Other Financial Ratios of AKUMS DRUGS & PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of AKUMS DRUGS & PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AKUMS DRUGS & PHARMACEUTICALS ₹8,279.2 Cr 4% 12% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,032.0 Cr 0.9% 2.2% 23.9% Stock Analytics
DIVIS LABORATORIES ₹162,252.0 Cr 3.3% 4.7% 58% Stock Analytics
CIPLA ₹124,457.0 Cr 0.5% 2% 11.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,425.0 Cr -0.4% 2.8% 24.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,152.8 Cr -0.8% -0.4% 0.8% Stock Analytics


AKUMS DRUGS & PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AKUMS DRUGS & PHARMACEUTICALS

4%

12%

NA
SENSEX

0.9%

3%

8.9%


You may also like the below Video Courses